Abstract
Photoaffinity labeling is an important, extremely valuable tool for the characterization of pharmacological receptors. Radioactive photoaffinity probes allow, even in crude preparations with very low receptor densities, identification of the polypeptide(s) which bind the ligand. In general, the photoaffinity protection profile (obtained by adding unlabeled compounds interacting competitively or allosterically with the receptor) should reflect the reversible binding interaction profile. In Ca2+ channel research, three arylazide photo affinity probes are useful, namely ( - )- or (±)[3H]azidopine (1,4-dihydropyridines), [N-methyl-3H]LU49888 (a phenylalkylamine), and an azido derivative of [125I]ω-conotoxin GVIA (CgTx). The first two ligands are well characterized by reversible binding experiments and interact in a stereoselective manner and with high affinity with L-type Ca2+ channels [1-5]. The 125I-iodinated CgTx photoaffinity probe presumably incorporates into the N-type channel components, exclusively found in neuronal tissues [6]. L-type Ca2+ channels have distinct drug-receptor domains for different classes of drugs (e.g., the 1,4-dihydropyridines, phenylalkylamines, and benzothiazepines) linked to each other (and to high- and low-affinity divalent cation binding sites) by reciprocal allosteric coupling mechanisms [7]. Recently, the benzothiazinones [8] and diphenylbutylpiperidines [9, 10] have been suggested to act at yet another site.
Research of H. G. was supported by the Deutsche Forschungsgemeinschaft, Dr. Legerlotz Foundation, and Jubiläumsfonds der Nationalbank. H.G. and H.S. are funded by a Schwerpunktprogramm of the Austrian Fonds zur Förderung der Wissenschaftlichen Forschung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Striessnig J, Knaus HG, Grabner M, Moosburger K, Seitz W, Lietz H, Glossmann H (1987) Photoaffinity labeling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett 212:247–253
Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A (1987) Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chern 262:14337–14342
Leung AT, Imagawa T, Campbell KP (1987) Structural characterization of the 1,4-dihydropyridine receptor of the voltage-dependent calcium channel from rabbit skeletal muscle. Evidence for two distinct high molecular weight subunits. J Biol Chern 262:7943–7946
Flockerzi V, Oeken HJ, Hofmann F (1986) Purification of a functional receptor for calcium channel blockers from rabbit skeletal muscle microsomes. Eur J Biochem 161:217–224
Takahashi M, Seagar MJ, Jones JF, Reber BFX, Catterall WA (1987) Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle. Proc Natl Acad Sci USA 84:5478–5482
Abe T, Saisu H (1987) Identification of the receptor for omega-conotoxin in brain. J Biol Chern 262:9877–9882
Glossmann H, Ferry DR, Rombusch M (1984) Molecular pharmacology of the calcium channel: Evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4 dihydropyridine calcium channel label. [125IJiodipine. J Cardiovasc harmacol 6:608–621
Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R (1988) Evidence for a distinct calcium antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn Schmiedeberg’s Arch Pharmacol 337 :331–340
Galizzi JP, Fosset M, Romey G, Laduron P, Lazdunski M (1986 a) Neuroleptics ofthe diphenylbutylpiperidine series are potent calcium channel inhibitors. Proc Natl Acad Sci USA 83:7513–7517
King VF, Garcia ML, Kaczorowski GJ (1988) Interaction of fluspirilene with cardiac L-type calcium channels. Biophys J 53:557 a
Fosset M, Jaimovich E, Delpont E, Lazdunski M (1983) [3H]Nitrendipine receptors in skeletal muscle. J Biol Chern 258:6068–6092
Glossmann H, Ferry DR, Boschek CB (1983) Purification of the putative calcium channel from skeletal muscle with the aid of [3H]nimodipine binding. Nauny Schmiedeberg’s Arch Pharmacol 323:1–11
Ferry DR, Rombusch M, Goll A, Glossmann H (1984) Photoaffinity labeling of Ca2+ channels with P[3H]azidopine. FEBS Lett 169:112–118
Ferry DR, Kümpf K, Goll A, Glossmann H (1985) Subunit composition of skeletal muscle transverse tubule calcium channel evaluated with the 1,4-dihydropyridine photoaffinity probe, P[3H]azidopine. EMBO J 4:1933–1940
Sieber M, Nastainczyk W, Zubor V, Wernet W, Hofmann F (1987) The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel. Eur J Biochem 167:17–122
Pauron D, Qar J, Barhanin J, Fournier D, Cuany A, Pralavorio M, Berge JB, Lazdunski M (1987) Identification and affinity labeling of very high affinity binding sites for the phenylalkylamine series of calcium channel blockers in the Drosophila nervous system. Biochemistry 26:6311–6315
Pastan I, Gottesmann M (1987) Multiple-drug resistance in human cancer. N Engl J Med 316:1388–1393
Striessnig J, Zernig G, Glossmann H (1985) Human red-blood-cell calcium antagonist binding sites. Eur J Biochem 150:67–77
Zernig G, Glossmann H (1988) A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney. Biochem J 252: in press
Dolle R, Nultsch W (1988) Specific binding of the calcium channel blocker [3H]verapamil to membrane fractions of Chlamydomonas reinhardtii. Arch Microbiol 149:451–458
Dolle R, Nultsch W (1988) Characterization of d-[3H]cis-diltiazem binding to membrane fractions and specific binding of calcium channel blockers to isolated flagellar membrane of Chlamydomonas reinhardtü. Biologists in press
Dolle R (1988) Isolation of plasma membrane and binding of the calcium antagonist nimodipine in chlamydomonas reinhardtü. Physiologia Plant in press
Striessnig J, Moosburger K, Goll A, Ferry DR, Glossmann H (1986) Stereoselective photoaffinity labeling of the purified l,4-dihydropyridine receptor of the voltage-dependent calcium channel. Eur J Biochem 161:603–609
Glossmann H, Ferry DR, Striessnig J, Goll A, Moosburger K (1987) Resolving the structure of the calcium channel by photoaffinity labeling. Trends Pharmacol Sci 8:95–100
Glossman H, Ferry DR, Lübbecke F, Mewes R, Hofmann F (1981) Calcium channels: direct identification with radioligand binding studies. Trends Pharmacol Sci 3:431–437
Triggle DJ, Swamy VC (1983) Calcium antagonists. Circ Res 52:17–28
Janis RA, Silver PJ, Triggle DJ (1987) Drug action and cellular calcium regulation. Advances Drug Res 16:309–591
Reynolds D, Snowman AD, Snyder SH (1986) (-)- [3H]Desmethoxyverapamillabels multiple calcium channel modulator receptors in brain and skeletal muscle: Differentiation by temperature and dihydropyridines. J Pharmacol Exp Ther 237:731–738
Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G (1985) Calcium channels: Basic properties as revealed by radioligand binding studies. J Cardiovasc Pharmacol 7:S20-S30
Cruz U, Olivera BM (1986) Calcium channel antagonist. J Biol Chern 261:6230–6233
McCleskey EW, Fox A, Feldman DH, Cruz U, Olivera BM, Tsien RW, Yoshikami D (1987) Omega-conotoxin: Direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc Natl Acad Sci USA 84:4327–4331
Abe T, Koyano K, Saisu H, Nishiuchi Y, Sasakibara S (1986) Binding of omega-conotoxin to receptor sites associated with the voltage-sensitive calcium channel. Neurosci Lett 71:203–208
Knaus HG, Striessnig J, Koza A, Glossmann H (1987) Neurotoxic aminoglycoside antibiotics are potent inhibitors of P[125I]J-omega-conotoxin binding to guinea-pig cerebral cortex membranes. Naunyn Schmiedeberg’s Arch Pharmacol 336:583–586
Wagner JA, Snowman AD, Snyder SH (1987) Aminoglycoside effects on voltage-sensitive calcium channels and neurotoxicity. N Engl J Med 317:1669
Morton ME, Froehner SC (1987) Monoclonal antibody identifies a 200 kDa subunit of the dihydropyridine-sensitive calcium channel. J Biol Chern 262:11904–11907
Leung AT, Imagawa T, Block B, Franzini-Armstrong C, Campbell KP (1988) Biochemical and ultrastructural characterization of the l,4-dihydropyridine receptor from rabbit skeletal muscle. J Biol Chern 263:994–1001
Takahashi M, Catterall WA (1987) Identification of an alpha-subunit of dihydropyridine-sensitive brain calcium channels. Science 236:88–91
Schmid A, Barhanin J, Coppola T, Borsotto M, Lazdunski M (1986) Immunochemical analysis of subunit structures of 1,4 dihydropyridine receptors associated with voltage-dependent calcium channels in skeletal, cardiac, and smooth muscles. Biochemistry 25:3492–3495
Vandaele S, Fosset M, Galizzi JP, Lazdunski M (1987) Monoclonal antibodies that coimmunoprecipitate the 1,4 dihydropyridine and phenylakylamine receptors and reveal the calcium channel structure. Biochemistry 26:5–9
Striessnig J, Knaus HG, GIossmann H (1988) Photoaffinity labeling of the calcium-channelassociated l,4-dihydropyridine and phenylakylamine receptor in guinea-pig hippocampus. Biochem J 252 in press
Tanabe T, Takeshima H, Mikami A, Flockerzi V, Takahashi H, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S (1987) Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328:313–318
Hofmann F, Nastainczyk W, Röhrkasten A, Schneider T, Sieber M (1987) Regulation of the L-type calcium channel. Trends Pharmacol Sci 8:393–398
Curtis BM, Catterall WA (1985) Phosphorylation of the calcium antagonist receptor of the voltage-sensitive calcium channel by cAMP-dependent protein kinase. Proc Natl Acad Sci USA 82:2528–2532
Glossmann H, Striessnig J, Hymel L, Schindler H (1987) Purified L-type calcium channels: only one single polypeptide (alpha1 subunit) carries the drug receptor domains and is regulated by protein kinases. Biomed Biochem Acta 46:S351–356
Nastainczyk W, R6hrkasten A, Sieber M, Rudolph C, Schächtele C, Marme D, Hofmann F (1987) Phosphorylation ofthe purified receptorfor calcium channel blockers by cAMP kinase and protein kinase C. Eur J Biochem 169:137–142
Curtis BM, Catterall WA (1983) Solubilization of the calcium antagonist receptor from rat brain. J Biol Chern 258:7280–7283
Flockerzi V, Oeken HJ, Hofmann F, Pelzer D, Cavalie A, Trautwein W (1986a) The purified dihydropyridine-binding site from skeletal muscle T-tubulus is a functional calcium channel. Nature (London) 323:66–68
Smith JS, McKenna EJ, Ma J, Vilven J, Vaghy PL, Schwartz A, Coronado R (1987) Calcium channel activity in a purified dihydropyridine receptor preparation. Biochemistry 26:7182–7188
Talvenheimo JA, Worley III JF, Nelson MT (1987) Heterogeneity of calcium channels from a purified dihydropyridine receptor preparation. Biophys J 52:891–899
Hymel L, Striessnig J, Glossmann H, Schindler H (1988) Purified skeletal muscle 1,4 dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proc Natl Acad Sci USA 85: in press
Schwartz LM, McCleskey EW, Almers W (1985) Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels. Nature 314:747–751
Rios E, Brum G (1987) Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle. Nature 325:717–720
Agnew WS (1987) Dual roles for DHP receptors in excitation-contraction coupling. Nature 328:297
Schindler H (1988) Planar lipid-protein membranes: Strategies for formation and of detecting dependencies of ion transport functions on membrane conditions. Methods Enzymol 171 in press
Coronado R, Latorre R (1983) Phospholipid bilayers made from monolayers on patch-clamp pipettes. Biophys J 43:231–236
Ehrlich BE, Schen CR, Garcia ML, Kaczorowski GJ (1986) Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers. Proc Natl Acad Sci USA 83:193–197
Imagawa T, Smith JS, Coronado R, Campbell KP (1987) Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the calcium-permeable pore of the calcium release channel. J Bioi Chern 262: 16636–16643
Lansman JB, Hess P, Tsien RW (1986) Blockade of current through single calcium channels by Cd2+, Mg2+ and Ca2+. J Gen Physiol 88:321–347
Bellemann P, Ferry D, Lübbecke F, Glossmann H (1981) [3H]Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes. Drug Res 31 (II): 2064–2067
Garcia MK, King VF, Siegl PKS, Reuben JP, Kaczorowski GJ (1986) Binding of Ca2+-entry blockers to cardiac sarcolemmal membrane vesicles. J Bioi Chern 261:8146–8157
Ferry DR, Goll A, Glossmann H (1987) Photo affinity labeling of the cardiac calcium channel. Biochem J 243:125–135
Zernig G, Moshammer T, Graziadei I, Glossmann H (1988) Regulation of the novel mitochondrial dihydropyridine binding site by nucleotides. Naunyn-Schmiederberg’s Arch Pharmacol (abstr): in press
Glossmann H, Striessnig J (1988) Calcium channels. Vitam Horm in press
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Glossmann, H., Striessnig, J., Hymel, L., Zernig, G., Knaus, H.G., Schindler, H. (1988). The Structure of the Ca2+ Channel: Photoaffinity Labeling and Tissue Distribution. In: Morad, M., Nayler, W.G., Kazda, S., Schramm, M. (eds) The Calcium Channel: Structure, Function and Implications. Bayer AG Centenary Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73914-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-73914-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50061-2
Online ISBN: 978-3-642-73914-9
eBook Packages: Springer Book Archive